RAFAEL HOLDINGS INC - CLASS BShare · US75062E1064 · RFL (XNYS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of RAFAEL HOLDINGS INC - CLASS B
No Price
01.05.2026 22:01
Current Prices from RAFAEL HOLDINGS INC - CLASS B
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NYSE
RFL
USD
01.05.2026 22:01
1,35 USD
0,08 USD
+6,34 %
IEX
RFL
USD
01.05.2026 17:53
1,31 USD
0,04 USD
+3,15 %
ESG Risk Rating
BGood
Share Float & Liquidity
Free Float68,61 %
Shares Float25,21 M
Shares Outstanding36,75 M
Company Profile for RAFAEL HOLDINGS INC - CLASS B Share
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
